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Objectives The objective of this study was to compare the consistency in appropriate use criteria (AUC) ratings among a
broad range of practicing cardiologists and the AUC Technical Panel.
Background AUC for coronary revascularization have been developed by selected experts.
Methods Before AUC publication, 85 cardiologists from 10 U.S. institutions assessed the appropriateness of coronary re-
vascularization for 68 indications that had been evaluated by the AUC Technical Panel. Each indication was clas-
sified as appropriate, uncertain, or inappropriate, based on the physician group’s median rating. Rates of concor-
dance between the physician group and the AUC Technical Panel (i.e., same appropriateness category
assignment) and rates of nonagreement within the physician group (25% of panelists’ ratings outside the
group’s appropriateness category assessment) were determined.
Results Overall concordance between the 2 groups was 84%. Among indications classified as appropriate by the AUC
Technical Panel, concordance between the 2 groups was excellent (94% [34 of 36]); however, nonagreement within
the physician group was 44% (16 of 36). Among indications classified as uncertain, there was 73% (16 of 22) concor-
dance between the 2 groups. Among inappropriate indications, concordance was moderate (70% [7 of 10]), but non-
agreement occurred frequently (70% [7 of 10]). Moreover, there was substantial variation in appropriateness ratings
between individual physicians and the AUC Technical Panel (weighted kappa range: 0.05 to 0.76).
Conclusions Although there was good concordance in assessments of appropriateness for coronary revascularization be-
tween physicians and the AUC Technical Panel, nonagreement within the physician group was common and
there was marked variation in ratings between individual physicians and the AUC Technical Panel. (J Am Coll
Cardiol 2011;57:1546–53) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.050Although few debate the potential of coronary artery bypass
grafting or percutaneous coronary intervention to confer
substantial mortality and quality of life benefits in selected
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these procedures have emerged. As a result, national soci-
eties have developed the appropriate use criteria (AUC) for
coronary revascularization to support the efficient and ratio-
nal use of these procedures.
See pages 1554 and 1557
Although the technical panel that created the AUC
included a diverse range of perspectives and based their
recommendations upon clinical guidelines, it is unknown
whether appropriateness assessments might differ among a
broader range of cardiologists, including those in community-
based settings. Understanding the extent of concordance in
appropriateness ratings between the expert panel and a more
diverse group of practitioners can validate scenarios for which
there is broad consensus or highlight the need for either
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to clinical practice. It can also indicate the likelihood of
widespread acceptance and adoption of the AUC. Accord-
ingly, we surveyed cardiologists with a representative sample
of the same clinical indications as those rated by the AUC
Technical Panel and examined both their concordance and
the variation in their distribution of appropriateness ratings
with the AUC Technical Panel.
Methods
Development of the AUC. The methodology to develop
the AUC for coronary revascularization has been previously
described (1). Briefly, the AUC Technical Panel included
17 members (4 interventional cardiologists, 8 noninterven-
tional cardiologists, 4 cardiac surgeons, and 1 payer) who
rated the appropriateness of coronary revascularization for
174 distinct clinical indications based upon different com-
binations of: 1) clinical presentation (acute vs. nonacute);
2) angina severity (asymptomatic or Canadian Cardiovas-
cular Society [CCS] class); 3) extent of ischemia on nonin-
vasive functional testing (low, intermediate, or high risk);
4) high-risk clinical features (e.g., left ventricular dysfunc-
tion); 5) extent of anti-ischemic medical therapy; and
6) extent of anatomic disease based on angiography (number
of diseased coronary arteries with or without proximal left
anterior descending [LAD], left main, or bypass graft
disease). Moreover, the AUC Technical Panel evaluated the
relative appropriateness of percutaneous coronary interven-
tion and coronary artery bypass grafting for 24 additional
scenarios.
Based upon the median score of the AUC Technical
Panel for each clinical indication (range 1 to 9), clinical
indications were categorized as “appropriate” (median 7 to
9), “uncertain” (4 to 6), or “inappropriate” (1 to 3). In
addition, rates of nonagreement were determined to assess
variations in panelists’ ratings of appropriateness for a given
clinical scenario. Nonagreement occurred when 25% of
the individual panelists’ ratings fell outside the 3-point
region for that indication (2). To accomplish this, the
American College of Cardiology Foundation (ACCF)
made available to us the final ratings of each AUC Tech-
nical Panel member.
Description of study survey. In 2008, before the release of
the AUC, permission was obtained from the ACCF to
replicate the appropriateness ratings process in a cohort of
clinicians. Two of the investigators (P.S.C. and J.A.S.)
reviewed and selected 68 representative indications evalu-
ated by the AUC Technical Panel for this study’s survey
(Online Appendix). For the survey, one-third of the AUC’s
indications were chosen to minimize respondent burden,
but the selected indications reflected a diverse range of
clinical scenarios.
Select cardiologists from 10 institutions (Online Appen-
dix) were electronically mailed the study survey. Because the
AUC were not yet published, none of the survey partici-pants had access to the AUC
Technical Panel’s ratings. Study
participants were provided the
same explanatory documents, ta-
bles and figures, references, and
appendices that had been given
to the AUC Technical Panel.
Statistical analysis. For each of
the 68 clinical indications, the
median and distribution of ap-
propriateness ratings from study
participants were determined.
From the median value, the phy-
sician group’s assignment of ap-
propriateness category was determined for each indication
using the method described earlier.
Concordance of appropriateness category assignments
(e.g., appropriate, uncertain, inappropriate) for each clinical
indication was compared between the physician group and
the AUC Technical Panel with descriptive plots. Summa-
ries of concordance results were tabulated overall and
stratified by whether the AUC Technical Panel had cate-
gorized an indication as appropriate, uncertain, or inappro-
priate. Analyses were then repeated after dividing the
physician group by interventional status, years in practice
(15 years vs. 15 years), and percent of time dedicated to
research (10% vs. 10%).
For examination of variation in appropriateness assign-
ments, the presence of nonagreement for each indication
within the physician group was assessed. In addition, to
examine the extent of variation between individual physi-
cians and the AUC Technical Panel, we computed weighted
kappa statistics between each individual physician and the
Technical Panel for all 68 clinical indications and examined
the distribution of weighted kappas within the physician
group.
Finally, we examined which clinical factors (coronary
anatomy, extent of ischemia on noninvasive functional
testing, severity of symptoms, and intensity of anti-ischemic
therapy) predicted nonagreement within the physician
group using multivariable hierarchic regression, with indi-
cations clustered by physician and physicians clustered by
institution. All analyses were conducted with SAS version
9.2 (SAS Institute, Inc., Cary, North Carolina) and R
version 2.6.2.
Results
A total of 85 physicians from 10 (2 community, 7
university-affiliated, and 1 university-owned) institutions
completed the study survey. Among the physician respon-
dents, 44 (51.8%) were interventional and 41 (48.2%) were
noninterventional cardiologists. All but 2 (97.6%) were
board certified in cardiology, the median number of years in
Abbreviations
and Acronyms
ACCF  American College
of Cardiology Foundation
AUC  appropriate use
criteria
CCS  Canadian
Cardiovascular Society
CI  confidence interval
LAD  left anterior
descending
RR  rate ratiopractice was 14.5 (interquartile range: 7.5 to 20.0 years;
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spent in research was 5% (interquartile range: 0% to 15%;
range 0% to 75%). Overall, there was good concordance
(84%) in appropriateness category assignments between the
physician group and the AUC Technical Panel for the 68
indications. However, rates of nonagreement were 66% in
the physician group.
Clinically appropriate indications. For the 36 clinical
indications identified as appropriate by the AUC Technical
Panel, there was excellent concordance, with the physician
group rating the indications as appropriate 94% (34 of 36) of
the time (Fig. 1, Table 1). Both interventional and nonin-
terventional cardiologists rated the vast majority of these
indications as appropriate (Online Appendix), and physi-
Figure 1 Appropriateness Ratings by the Physician Group for 3
The Online Appendix describes each clinical scenario. Red X  median rating of A
the physician group; blue bar  interquartile range for the physician group’s ratingcian ratings did not differ by number of years in practice or
percent of time dedicated to research (Table 1). There was,
however, greater variation (i.e., wider distribution) in the
ratings among physicians in this study than in the AUC
Technical Panel. Whereas the Technical Panel had non-
agreement in 31% (11 of 36) of the clinical indications
categorized as appropriate, the physician group had non-
agreement in 44% (16 of 36) of the indications (Table 2).
Clinically uncertain indications. For the 22 clinical indi-
cations rated as uncertain by the AUC Technical Panel,
both groups rated the indications as uncertain 73% (16 of
22) of the time (Table 1). Of the 6 discordant indications,
the physician group rated 3 scenarios (12c, 14c, and 57b) as
appropriate and 3 (25a, 28a, and 50a) as inappropriate
propriate Indications
iate Use Criteria Technical Panel; yellow dot  median rating of
of the circles  weighted distribution of ratings by the physician group.6 Ap
ppropr
s; size
v
d
n
s
g
(
ions ass
xamine
1549JACC Vol. 57, No. 14, 2011 Chan et al.
April 5, 2011:1546–53 Concordance With Appropriateness Criteria(Fig. 2). Although there was similar concordance between
interventionalists and noninterventionalists with the AUC
Technical Panel, physicians with 10% time dedicated to
research had higher concordance with the AUC Technical
Panel than physicians with 10% research time (Table 1).
Finally, rates of nonagreement for scenarios categorized as
uncertain were 100% in the physician group (22 of 22) and
82% (18 of 22) in the AUC Technical Panel.
Clinically inappropriate indications. For the 10 clinical
indications identified as inappropriate by the AUC Tech-
nical Panel, the physician group assigned an inappropriate
classification for only 70% (7 of 10) of the indications
categorized as inappropriate by the AUC Technical Panel
(Fig. 3, Table 1), with 100% concordance among noninter-
entional cardiologists and 70% among interventional car-
iologists (Online Appendix). Importantly, there was sig-
ificant variation among physician ratings for these clinical
cenarios, with nonagreement rates of 70% in the physician
roup compared with 20% in the AUC Technical Panel
Table 2). Interventionalists and physicians with 10%
research time had lower rates of nonagreement than their
counterparts.
Predictors of nonagreement among physicians. In a mul-
tivariable model, the presence of a proximal LAD stenosis
was associated with higher rates of physician nonagreement
(adjusted rate ratio [RR]: 1.29 [95% confidence interval
(CI): 1.11 to 1.51]; p  0.001), suggesting greater variabil-
ity in ratings of appropriateness within the physician group
when the proximal LAD was involved (Table 3). In con-
trast, a high-risk noninvasive study for ischemia (adjusted
RR: 0.51 [95% CI: 0.40 to 0.65]; p  0.0.001), maximal
Agreement Between the AUC Technical Panel and Survey Participain Ratings of Appropriateness for Coronary Rev scula izationTable 1 Agre ment Between the AUC Techni a Panel and Surin Ratings of Appropriateness for Coronary Revascular
Indications n
All Physicians
(n  85)
Interventionali
Yes
(n  44)
All 68 84% 84%
Appropriate 36 94% 94%
Uncertain 22 73% 73%
Inappropriate 10 70% 70%
For each of the 68 clinical indications, we compared the concordance of the appropriateness catego
(AUC) Technical Panel. Analyses were conducted for all indications, as well as separately for indicat
for specific subgroups (interventionalist, years in practice, and percent research time) were also e
Rates of Nonagreement in Ratings of Appropriateness Within EachTable 2 Rates of Nonagreement in Ratings of Appropriateness
Indications
Technical Panel
(n  17)
All Physicians
(n  85)
Interve
Yes
(n  44)
All 46% 66% 59%
Appropriate 31% 44% 36%
Uncertain 82% 100% 100%
Inappropriate 20% 70% 63%
Rates of nonagreement (25% of panelists’ ratings outside the 3-point appropriateness region fo
group, stratified by whether the indication was categorized as appropriate, uncertain, or inappropriate in t
indications categorized as inappropriate.intensity (i.e., 2 or more agents) of anti-ischemic therapy
(adjusted RR: 0.75 [95% CI: 0.69 to 0.82]; p  0.001), and
substantial (CCS class III to IV) symptoms (adjusted RR:
0.46 [95% CI: 0.38 to 0.57]; p  0.001) were each
associated with significantly lower rates of physician
nonagreement.
Variation between individual physicians and AUC Technical
Panel. The distribution of weighted kappa statistics
between individual physicians and the AUC Technical
Panel for all 68 indications was wide, ranging from 0.05
to 0.76, with the average weighted kappa for all physi-
cians of 0.52 (Fig. 4). This suggests marked variation in
appropriateness assignments between individual physi-
cians and the AUC Technical Panel, with certain physi-
cians almost never agreeing with the AUC Technical
Panel for any of the surveyed indications and no physi-
cian achieving uniform concordance with the AUC
Technical Panel.
Discussion
In this study, we compared ratings of clinical appropriate-
ness for coronary revascularization between practicing clini-
cians and members of the AUC Technical Panel. We found
there was excellent concordance (94%) between the 2 groups
for clinical indications categorized as appropriate but only
modest concordance (70%) for clinical indications catego-
rized as inappropriate. However, there was wide variation
(i.e., nonagreement) in ratings of appropriateness among
physicians, with more than 25% of physicians assigning an
appropriateness category different than the group as a whole
articipants
n
Years in Practice Research Time
1)
<15
(n  38)
>15
(n  38)
<10%
(n  49)
>10%
(n  36)
87% 84% 85% 87%
92% 94% 94% 92%
77% 73% 73% 86%
90% 70% 80% 70%
nment (based on themedian rating) between the physician group and the Appropriate Use Criteria
igned as appropriate, uncertain, and inappropriate by the AUC Technical Panel. Concordance rates
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variation in appropriateness category assignments be-
tween individual physicians and the AUC Technical
Panel, with some physicians almost never agreeing with
the AUC Technical Panel and no physician achieving
more than 80% agreement. Collectively, our findings
suggest that although there is general concordance in
ratings of clinical appropriateness between practicing
cardiologists and the AUC Technical Panel, there is not
uniform agreement between the 2 groups, with markedly
different opinions among individual physicians, even after
reviewing existing evidence.
An important strength of this study is that the physician
ratings were obtained before the publication of the ACC’s
Figure 2 Appropriateness Ratings by the Physician Group for 2
See Figure 1 for description.UC for coronary revascularization in early 2009. Thisavoided potential contamination of survey results by respon-
dents from the views of the AUC Technical Panel. Impor-
tantly, the physician group received similar instructions and
access to clinical guidelines for coronary revascularization as
the AUC Technical Panel to derive their appropriateness
ratings.
Our findings suggest that there was substantial within-
group heterogeneity in ratings of appropriateness among the
physicians surveyed. More than 1 in 4 physicians rated an
indication for coronary revascularization as uncertain or inap-
propriate for 43% of indications categorized as appropriate by
the AUC and rated an indication as uncertain or appropriate
for 70% of the inappropriate indications. Notably, physicians’
rates of nonagreement were lower for those indications involv-
certain Indications2 Uning severe CCS class III to IV angina symptoms and high-risk
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revascularization are likely to be greater. Conversely, there was
more divergence of opinion in the setting of significant
proximal LAD obstruction, suggesting that some clinicians
presumably viewed its treatment as life prolonging, whereas
others did not.
The broad range of kappa statistics between individual
physicians and the AUC Technical Panel, none of which
exceeded 0.76, highlights the variability in current opinions
about the roles of coronary revascularization in the care of
patients with coronary artery disease. More research and
better translation of existing knowledge to clinical practice
to clarify the appropriateness of certain clinical indications,
especially for those indications for which appropriateness
Figure 3 Appropriateness Ratings by the Physician Group for 1
See Figure 1 for description.was uncertain or when nonagreement existed, are needed.Given this variability in the appropriateness ratings, it is
expected that clinicians will vary greatly in their AUC
ratings for coronary revascularization. We believe that it will
be important to both measure and provide feedback to
clinicians about the appropriateness of patients that they
treat, while concurrently educating them about the AUC, if
more uniform practice is to be achieved.
Study limitations. Our study should be interpreted in the
context of the following limitations. Our survey methodol-
ogy differed somewhat from that of the AUC Technical
Panel because there were no face-to-face meetings to discuss
cases for which divergent assessments were made. Second,
our survey was conducted among clinical cardiologists from
only 10 U.S. institutions, and we did not assess ratings of
ppropriate Indications0 Inaappropriateness among cardiac surgeons. Third, although
modified Poisson regression models adjusting for scenario characteristics an
CCS  Canadian Cardiovascular Society; CI  confidence interval; LAD  le
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of clinical practices than the AUC Technical Panel, it did
not capture all geographic regions of the U.S. Fourth, we
did not have sufficient sample size to examine other sub-
groups of interest or obtain more detailed data on charac-
teristics of survey respondents.
Conclusions
We found good concordance for ratings of appropriateness
for coronary revascularization between a diverse group of
cardiologists and the Technical Panel for the AUC for
coronary revascularization. However, there was substantial
variation in ratings of appropriateness between individual
physicians and the AUC Technical Panel, as well as
nonagreement in appropriateness category assignments
among cardiologists for a number of indications. These
findings suggest that more research to understand these
variations, along with additional education about procedural
appropriateness, may help achieve greater uniformity in the
appropriate use of coronary revascularization.
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ft anterior descending; RR  rate ratio; SVG  saphenous vein graft.Clinical Predictors of Nonagreement Within the PhysTable 3 Clinical Predictors of Nonagreement Wit
Scenarios Evaluated Nonagree
Diseased vessels
1 28, 29 39
2 34, 35 39
1 to 2 14, 15 32
3 42, 43 32
Proximal LAD
No 12, 13 30
Yes 28, 29, 34, 35 39
SVG stenosis
No 56, 57 39
Yes 50, 51 40
Noninvasive testing
Low risk 12, 13 30
Intermediate risk 14, 15 32
Low risk 34, 35 39
High risk 38, 39 19
Medication intensity
None/minimal 12–56 39
Maximal 13–57 29
CCS class
Asymptomatic 12–57 a 43
I–II 12–57 b 40
III–IV 12–57 c 20
*The proportion of physician ratings outside the appropriateness categoryFigure 4
Agreement in Appropriateness Category
Assignments Between Individual Physicians
and the AUC Technical Panel
Distribution of individual physician agreement with the Appropriate Use Criteria (AUC)
Technical Panel, as measured by weighted kappa statistics.have been possible.
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APPENDIX
For a description of the survey instrument used for physicians in this study,
the list of institutions recruited for this study, and comparisons of appro-vascular Angiography and Interventions, Society of Thoracic Surgeons,
American Association for Thoracic Surgery, American Heart Associa- priateness ratings, please see the online version of this article.
